156 related articles for article (PubMed ID: 11251016)
1. Development of inhalational agents for oncologic use.
Sharma S; White D; Imondi AR; Placke ME; Vail DM; Kris MG
J Clin Oncol; 2001 Mar; 19(6):1839-47. PubMed ID: 11251016
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized chemotherapy.
Gagnadoux F; Hureaux J; Vecellio L; Urban T; Le Pape A; Valo I; Montharu J; Leblond V; Boisdron-Celle M; Lerondel S; Majoral C; Diot P; Racineux JL; Lemarie E
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):61-70. PubMed ID: 18518832
[TBL] [Abstract][Full Text] [Related]
3. Formulations for pulmonary administration of anticancer agents to treat lung malignancies.
Carvalho TC; Carvalho SR; McConville JT
J Aerosol Med Pulm Drug Deliv; 2011 Apr; 24(2):61-80. PubMed ID: 21410326
[TBL] [Abstract][Full Text] [Related]
4. Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices.
Yu XY; Jin X; Shou ZX
Drug Deliv; 2021 Dec; 28(1):1995-2010. PubMed ID: 34569401
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities.
Mangal S; Gao W; Li T; Zhou QT
Acta Pharmacol Sin; 2017 Jun; 38(6):782-797. PubMed ID: 28504252
[TBL] [Abstract][Full Text] [Related]
6. [Inhaled chemotherapy - Part 1: General concept and current technological challenges].
Rosière R; Hureaux J; Levet V; Amighi K; Wauthoz N
Rev Mal Respir; 2018 Apr; 35(4):357-377. PubMed ID: 29731372
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-directed drug delivery: influence of formulation and delivery devices.
Mulshine JL; Neckers L
Lung Cancer; 2004 Dec; 46(3):387-92. PubMed ID: 15541828
[TBL] [Abstract][Full Text] [Related]
8. Targeting the lung: preclinical and comparative evaluation of anticancer aerosols in dogs with naturally occurring cancers.
Khanna C; Vail DM
Curr Cancer Drug Targets; 2003 Aug; 3(4):265-73. PubMed ID: 12871057
[TBL] [Abstract][Full Text] [Related]
9. Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.
Guilleminault L; Azzopardi N; Arnoult C; Sobilo J; Hervé V; Montharu J; Guillon A; Andres C; Herault O; Le Pape A; Diot P; Lemarié E; Paintaud G; Gouilleux-Gruart V; Heuzé-Vourc'h N
J Control Release; 2014 Dec; 196():344-54. PubMed ID: 25451545
[TBL] [Abstract][Full Text] [Related]
10. The potential to treat lung cancer via inhalation of repurposed drugs.
Lee WH; Loo CY; Ghadiri M; Leong CR; Young PM; Traini D
Adv Drug Deliv Rev; 2018 Aug; 133():107-130. PubMed ID: 30189271
[TBL] [Abstract][Full Text] [Related]
11. The next generation therapy for lung cancer: taking medicine by inhalation.
Wang Z; Liu Z; Mei J; Xu S; Liu Y
Nanotechnology; 2021 Jul; 32(39):. PubMed ID: 34167099
[TBL] [Abstract][Full Text] [Related]
12. Aerosol Delivery in the Treatment of Lung Cancer.
Storti C; Le Noci V; Sommariva M; Tagliabue E; Balsari A; Sfondrini L
Curr Cancer Drug Targets; 2015; 15(7):604-12. PubMed ID: 26033086
[TBL] [Abstract][Full Text] [Related]
13. Aerosol therapy for malignancy involving the lungs.
Rao RD; Markovic SN; Anderson PM
Curr Cancer Drug Targets; 2003 Aug; 3(4):239-50. PubMed ID: 12871055
[TBL] [Abstract][Full Text] [Related]
14. [Enhanced chemotherapeutic drug delivery to tumor tissue by high intensity focused ultrasound].
Jung JT; Lee DH; Hwang JH
Korean J Gastroenterol; 2009 Apr; 53(4):216-20. PubMed ID: 19381053
[TBL] [Abstract][Full Text] [Related]
15. Inhaled chemotherapy in lung cancer: safety concerns of nanocomplexes delivered.
Zarogoulidis P; Giraleli C; Karamanos NK
Ther Deliv; 2012 Sep; 3(9):1021-3. PubMed ID: 23035587
[No Abstract] [Full Text] [Related]
16. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter.
Selting K; Waldrep JC; Reinero C; Branson K; Gustafson D; Kim DY; Henry C; Owen N; Madsen R; Dhand R
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):255-68. PubMed ID: 18759657
[TBL] [Abstract][Full Text] [Related]
17. Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.
Ibrahim BM; Tsifansky MD; Yang Y; Yeo Y
Expert Opin Drug Deliv; 2011 Apr; 8(4):451-66. PubMed ID: 21375469
[TBL] [Abstract][Full Text] [Related]
18. Immunocytokines: a novel class of potent armed antibodies.
Pasche N; Neri D
Drug Discov Today; 2012 Jun; 17(11-12):583-90. PubMed ID: 22289353
[TBL] [Abstract][Full Text] [Related]
19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
20. Delivery of anticancer drugs.
Zee-Cheng RK; Cheng CC
Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
